Canada’s Cannabis Safety Surveillance System: What Six Years of Adverse Reaction Reports Reveal
Cannabis safety pharmacovigilance in Canada from 2018 to 2024 highlights important patterns in adverse reaction reports. Most reports involve older adults using cannabis medically, with extracts frequently implicated. This surveillance data provides…
Most Physicians Are Open to Medical Cannabis but Lack the Knowledge to Prescribe Confidently
This review highlights the critical role of medical cannabis physician education in addressing knowledge gaps. Most physicians encounter patient demand but lack confidence to prescribe. Improving education is key to safe, evidence-informed medical…
2025 Study Shows No Link Between Cannabis Use and Cognitive Decline in Older Adults
The cannabis cognitive aging study 2025 found no evidence that cannabis use accelerates cognitive decline or dementia risk in older adults. This large observational study combined data from two major cohorts and Mendelian randomisation analyses. The…
Cannabis Pill Disrupts REM Sleep in Insomnia Patients but Leaves Next-Day Function Largely Intact
This cannabinoid clinical trials sleep insomnia study found that THC/CBD significantly decreased REM sleep duration and increased REM latency in insomnia patients. Despite these changes, next-day objective alertness remained largely intact. The study…
Major International Cannabis Study Designed—But No Results Yet
The international cannabis study protocol aims to track medicinal and recreational users across multiple countries using ecological momentary assessment. This longitudinal research design addresses key gaps in cannabis effects on mood and cognition.…
Inside the Regulatory Maze: What It Actually Takes to Get a Cannabis Drug FDA-Approved
Cannabis botanical drug development faces unique regulatory challenges that complicate FDA approval. The dual oversight by the FDA and DEA imposes significant hurdles for developers. Understanding these complexities is essential for advancing cannabinoid…
Cannabis Use Linked to Higher Depressive Symptoms in Women, but Study Cannot Establish Cause
This study examines cannabis use and depressive symptoms, highlighting a stronger association in women. Regular cannabis use in women is linked to higher odds of depressive symptoms. However, the study cannot establish causation between cannabis use and…
Who Drank and Used Cannabis More During COVID-19? Income and Identity Both Played a Role
This COVID-19 alcohol cannabis use income race gender Canada study reveals how income and identity influenced substance use during the pandemic. It highlights intersectional disparities in drinking and cannabis use. Understanding these factors helps…
Autistic Adults Report Symptom Relief After Cannabis Use—But Study Design Cannot Confirm It Works
The cannabis autism symptom tracking study 2025 reports a 73% reduction in symptoms among autistic adults after cannabis use. However, the study design limits confirmatory conclusions. This observational data highlights the need for controlled trials.
Cannabinoids Offer Modest Pain Relief but Fall Short of First-Line Status, Review Concludes
This cannabinoid analgesia review highlights modest, condition-specific pain relief from cannabinoids. Safety concerns and regulatory challenges limit their use to adjunctive therapy. Patients unresponsive to conventional treatments may consider…